Anthropic's Fable 5 AI model showcases advanced agentic coding, capable of autonomous complex task completion and outperforming benchmarks....

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Leading analyst Devarsh Vakil suggests Indian markets offer compelling buying opportunities now, with valuations correcting to attractive l...

Corporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...

Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...

Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...

Rudyard Kipling’s famous quote about travelling alone gives an important lesson about confidence, focus, and self-belief. The writer of The...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

San Francisco viral video: A viral video from San Francisco's Tenderloin neighborhood depicts a stark reality of widespread drug use, shock...

Maharashtra's Food and Drug Administration now mandates restaurants and eateries to clearly disclose if "paneer" is genuine or a substitute...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

With wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include popular drugs such a...

With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%.

India has also sought amendment of laws on unilateral action by members on trade issues.

In 2014, six global drug makers were fined EUR 427.7 million for striking deals to prevent entry of cheaper version of blood pressure drug ...

You would soon be able to find the most affordable alternative to the medicine prescribed by your doctor through an SMS-based service.